— Know what they know.
Not Investment Advice
Also trades as: 0Y6X.L (LSE) · $vol 1M · 2M6.DE (XETRA) · $vol 0M

MDT NYSE

Medtronic plc
1W: +1.1% 1M: +5.5% 3M: +1.1% YTD: -12.3% 1Y: -8.1% 3Y: +1.5% 5Y: -21.7%
$86.88
+2.66 (+3.16%)
 
Weekly Expected Move ±5.0%
$75 $79 $83 $87 $92
NYSE · Healthcare · Medical - Devices · Alpha Radar Buy · Power 68 · $111.2B mcap · 1.28B float · 0.785% daily turnover · Short 29% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$111.2B
52W Range73.31-106.33
Volume13,057,553
Avg Volume10,024,480
Beta0.58
Dividend$2.85
Analyst Ratings
30 Buy 21 Hold 0 Sell
Consensus Buy
Company Info
CEOGeoffrey Straub Martha
Employees95,000
SectorHealthcare
IndustryMedical - Devices
IPO Date1973-05-02
Building Two, Parkmore Business Park West
Galway, GA H91 4K49
IE
353 1 438 1700
About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Recent Insider Trades

NameTypeSharesPriceDate
Walter Matthew R. S-Sale 3,102 $83.15 2026-07-08
Thompson Kweli 22,363 $91.97 2026-06-26
Thompson Kweli 0 2026-06-18
Thompson Kweli 3,253 2026-06-18
Thompson Kweli 9,179 2026-06-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms